192 related articles for article (PubMed ID: 8007710)
1. Lobular carcinoma in situ (LCIS): pathology and treatment.
Gump FE
J Cell Biochem Suppl; 1993; 17G():53-8. PubMed ID: 8007710
[TBL] [Abstract][Full Text] [Related]
2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
3. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological survey of preinvasive breast cancer.
Vandenbroucke A; Bourdon C
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
[TBL] [Abstract][Full Text] [Related]
5. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for women with lobular carcinoma in situ (LCIS).
Oppong BA; King TA
Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
[TBL] [Abstract][Full Text] [Related]
7. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
[TBL] [Abstract][Full Text] [Related]
8. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
9. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
[TBL] [Abstract][Full Text] [Related]
10. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
[TBL] [Abstract][Full Text] [Related]
11. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?
Cutuli B; de Lafontan B; Quetin P; Mery E
Eur J Cancer; 2005 Feb; 41(3):380-5. PubMed ID: 15691636
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Goldstein NS; Kestin LL; Vicini FA
Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
[TBL] [Abstract][Full Text] [Related]
13. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
14. Lobular carcinoma in situ.
Afonso N; Bouwman D
Eur J Cancer Prev; 2008 Aug; 17(4):312-6. PubMed ID: 18562954
[TBL] [Abstract][Full Text] [Related]
15. Lobular carcinoma in situ of the breast.
Goldschmidt RA; Victor TA
Semin Surg Oncol; 1996; 12(5):314-20. PubMed ID: 8873318
[TBL] [Abstract][Full Text] [Related]
16. Risk counseling and management in patients with lobular carcinoma in situ.
Garreau JR; Nelson J; Look R; Walts D; Mahin D; Homer L; Johnson N
Am J Surg; 2005 May; 189(5):610-4; discussion 614-5. PubMed ID: 15862506
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
18. Lobular carcinoma of the breast in situ and infiltrating.
Wheeler JE; Enterline HT
Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ: current concepts and controversies.
Schnitt SJ; Morrow M
Semin Diagn Pathol; 1999 Aug; 16(3):209-23. PubMed ID: 10490198
[TBL] [Abstract][Full Text] [Related]
20. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]